Global manufacturer of cardiovascular medical devices BIOTRONIK announced the release of its Renamic product for the Japanese market. The announcement is in response to the dramatic growth of cardiac ...
BERLIN--(BUSINESS WIRE)--BIOTRONIK SE & Co. KG announced today the European market launch of their new Renamic implantable cardiac device programmer. Renamic is the latest addition to BIOTRONIK’s new ...
LAKE OSWEGO, Ore., Aug. 31, 2022 /PRNewswire/ -- BIOTRONIK's LiveSupport feature has been successfully used to remotely support Cardiac Rhythm Management (CRM) clinics. This new technology enables ...
LAKE OSWEGO, Ore.-- (BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has granted approval for its ...
First US Patients Implanted with Itrevia HF-T QP, Incorporating Latest Defibrillator Technology, Closed Loop Stimulation and Compatibility with a Quadripolar Lead, to Help Patients with Heart Failure ...